Hirakata, Japan

Masahiro Watanabe

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: The Green Cross Corporation, Ishihara Sangyo Kaisha, Ltd., Hoechst Japan Limited. Active years: 1988-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Watanabe. Retrieved from https://idiyas.com/inventor/masahiro-watanabe-fnfmucik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 150(Granted Patents)


Location History:

  • Hyogo, JP (1988 - 1990)
  • Akashi, JP (1988 - 1991)
  • Hirakata, JP (1991 - 1999)

Company Filing History:


Years Active: 1988-1999

Loading Chart...
Areas of Expertise:
Placental Blood Flow
Antiviral Agent
Pharmaceutical Composition
Benzoyl Urea
Indoleacetic Acid
Peptide Derivatives
Monoclonal Antibody
Hepatitis Treatment
Circulatory Disorders
Dihydropyridine Derivative
Antitumorous Compounds
Dispersant
16 patents (USPTO):Explore Patents

Title: **Masahiro Watanabe: Pioneering Innovations in Medical Science**

Introduction

Masahiro Watanabe, an accomplished inventor based in Hirakata, Japan, is known for his significant contributions to medical science through his innovative inventions. With a remarkable portfolio of 16 patents, Watanabe has dedicated his career to developing methods and agents that enhance health and improve quality of life.

Latest Patents

Among his latest patents, Watanabe has developed a groundbreaking method for increasing placental blood flow. This method utilizes a human-originated antithrombin-III to enhance blood flow, particularly beneficial in addressing intrauterine growth retardation (IUGR) caused by decreased circulation. This innovative approach emphasizes safety for both the mother and fetus, establishing a new standard in treating such conditions.

Another notable invention is a circulatory disorder improving agent that features a dihydropyridine derivative. This agent serves as an effective treatment for organ circulation disorders and peripheral circulation improvements, showcasing Watanabe's commitment to addressing critical health issues through innovative solutions.

Career Highlights

Throughout his career, Masahiro Watanabe has made substantial contributions while working for prestigious companies, including Green Cross Corporation and Ishihara Sangyo Kaisha, Ltd. His work in these organizations has been instrumental in advancing medical innovation and developing effective treatment methods.

Collaborations

Watanabe has collaborated with talented professionals, including his coworkers Kazumasa Yokoyama and Tsunetaka Nakajima. Their collective expertise and teamwork have played a significant role in fostering innovation and enhancing the efficacy of Watanabe's inventions.

Conclusion

Masahiro Watanabe exemplifies the spirit of innovation through his dedication to improving health outcomes. His numerous patents demonstrate his commitment to addressing significant medical challenges, setting the stage for future advancements in medical science. Through his work, Watanabe continues to inspire future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…